Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk

Roongruedee Chaiteerakij, Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Teresa A. Mettler, Zachary S. Fredericksen, W. Ray Kim, Gregory J. Gores, Rosebud O. Roberts, Janet E. Olson, Terry M. Therneau, Lewis R. Roberts – 11 October 2012 – The associations between diabetes, smoking, obesity, and intrahepatic cholangiocarcinoma (ICC) risk remain inconclusive. Metformin is purportedly associated with a reduced risk for various cancers. This case‐control study evaluated risk factors for ICC and explored the effects of metformin on ICC risk in a clinic/hospital‐based cohort.

Anomalous hepatic vein anatomy of left lateral section grafts and customized unification venoplasty for pediatric living donor liver transplantation

Shin Hwang, Ki‐Hun Kim, Dae‐Yeon Kim, Kyoung‐Mo Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Jung‐Man Namgoong, Gil‐Chun Park, David C. Cronin, Sung‐Gyu Lee – 8 October 2012 – In liver transplantation, a left lateral section (LLS) graft may have an unusual variant left hepatic vein (LHV) anatomy. This study was designed to analyze the incidence of unusual LHV variants and to determine technical methods for effective reconstruction in infant recipients weighing approximately 10 kg or less.

Subscribe to